CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
EQS Group
Issuer: CureVac / Key word(s): Annual Results
24.04.2024 / 13:06 CET/CEST
The issuer is solely responsible for the..
Issuer: CureVac / Key word(s): Annual Results
24.04.2024 / 13:06 CET/CEST
The issuer is solely responsible for the..
OAKBROOK TERRACE, Illinois, April 11, 2024 (GLOBE NEWSWIRE) -- (OAKBROOK TERRACE, Illinois, April 11, 2024) – Building on a..
SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a clinical-stage biotechnology company..